These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22233767)

  • 1. Decrease of the immunophilin FKBP52 accumulation in human brains of Alzheimer's disease and FTDP-17.
    Giustiniani J; Sineus M; Sardin E; Dounane O; Panchal M; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE
    J Alzheimers Dis; 2012; 29(2):471-83. PubMed ID: 22233767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
    Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
    Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-cleaved Tau-D(421) is colocalized with the immunophilin FKBP52 in the autophagy-endolysosomal system of Alzheimer's disease neurons.
    Meduri G; Guillemeau K; Dounane O; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE; Giustiniani J
    Neurobiol Aging; 2016 Oct; 46():124-37. PubMed ID: 27479154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau gene mutations and their effects.
    Goedert M
    Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegenerative tauopathies.
    Lee VM; Goedert M; Trojanowski JQ
    Annu Rev Neurosci; 2001; 24():1121-59. PubMed ID: 11520930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
    Meduri G; Guillemeau K; Daguinot C; Dounane O; Genet M; Ferrara L; Chambraud B; Baulieu EE; Giustiniani J
    J Alzheimers Dis; 2023; 94(1):313-331. PubMed ID: 37248902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
    Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior.
    Giustiniani J; Guillemeau K; Dounane O; Sardin E; Huvent I; Schmitt A; Hamdane M; Buée L; Landrieu I; Lippens G; Baulieu EE; Chambraud B
    FASEB J; 2015 Aug; 29(8):3171-81. PubMed ID: 25888602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
    Boutajangout A; Boom A; Leroy K; Brion JP
    FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
    Tolnay M; Sergeant N; Ghestem A; Chalbot S; De Vos RA; Jansen Steur EN; Probst A; Delacourte A
    Acta Neuropathol; 2002 Oct; 104(4):425-34. PubMed ID: 12200631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.
    Umeda Y; Taniguchi S; Arima K; Piao YS; Takahashi H; Iwatsubo T; Mann D; Hasegawa M
    Neurosci Lett; 2004 Apr; 359(3):151-4. PubMed ID: 15050686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
    Belrose JC; Masoudi R; Michalski B; Fahnestock M
    Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon 3 insert of tau protein in neurodegenerative diseases.
    Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
    Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations causing neurodegenerative tauopathies.
    Goedert M; Jakes R
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.